Search search Menu  Acquisitions Home About us Acquisitions About us  One of our strategic pillars is developing and growing our market leading positions. We supplement our organic growth by successfully acquiring and integrating complementary businesses which strengthen our market positions. 2021 PHMR In January 2021, Ashfield completed the acquisition of PHMR Limited (“PHMR”), a market access consultancy employing over 40 people in the UK and Ireland. 2020 Canale Communications We acquired Canale Communications, an award-winning San Diego-based strategic communications agency. Visit website 2019 Incisive Health We acquired Incisive Health, a UK-based healthcare communications consultancy, which specialises in healthcare policy, public affairs and communication services. Visit website 2019 Putnam Associates We acquired Putnam Associates, a US-based specialist consultancy focused on product commercialisation strategy, exclusively for the life sciences industry. Visit website 2018 Create NYC We acquired Create NYC, a New York-based disruptive creative communications agency offering the tactical execution of sales and marketing materials for its international pharmaceutical clients. Visit website 2018 SmartAnalyst The acquisition of SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business, focused on the pharmaceutical and biotech sector. Visit website 2017 Sellxpert We acquired Sellxpert, a German and Swiss contract sales outsourcing business, based in Speyer, Germany and Basel, Switzerland, cementing our footprint in the DACH region. 2017 Vynamic The acquisition of Vynamic, a US-based healthcare industry management consultancy, further strengthened and expanded our Advisory offering. Visit website 2017 Cambridge Biomarketing We acquired Cambridge Biomarketing, a full-service advertising and communications agency focused on orphan diseases and specialty markets. Visit website 2017 MicroMass Communications Our final acquisition of 2017 was the acquisition of MicroMass Communications, a US-based healthcare communications agency specialising in behavioural change. Visit website 2016 STEM Marketing The acquisition of STEM Marketing was our first move into the Advisory space. STEM is the leading global provider of commercial, marketing and medical audits to pharmaceutical companies. Visit website 2016 Pegasus In 2016, we acquired Pegasus, one of the most successful integrated healthcare communications consultancies in the UK. Visit website 2015 CMIC Ashfield We formalised our joint venture with CMIC in 2015, creating CMIC Ashfield, a contract sales solution in Japan. Visit website 2014 Galliard and Nyxeon The acquisition of Galliard and Nyxeon in 2014, diversified our healthcare communications portfolio to include scientific PR. 2014 KnowledgePoint360 KnowledgePoint360 is our largest acquisition to date, making Ashfield a global market leader in healthcare communications. 2013 Expansis This Spanish CSO deepened Ashfield’s commercial presence in Europe. 2013 Medical Communications Group The acquisition of Medical Communications Group (MCG), a Canadian-based commercial services provider strengthened our offering in Canada. 2012 Pharmexx Through the acquisition of Pharmexx, we added true international reach and depth to our contract sales capabilities through our expansion into 8 new countries. Visit website 2012 Bilcare The acquisition of Bilcare in the US and the UK added clinical trial and supply chain packaging expertise to our packaging portfolio. Visit website 2012 WaterMeadow Medical WaterMeadow Medical was acquired in 2012. 2012 Drug Safety Alliance Drug Safety Alliance was acquired in 2012. 2012 Synopia RX Synopia RX was acquired in 2012. POPULAR PAGES At a glance Our divisions Press Releases & News STAY INFORMED Sign up for email alerts GET CONNECTED OFFICE DETAILS UDG Healthcare 20 Riverwalk Citywest Business Campus Citywest Dublin 24 Ireland OTHER UDG HEALTHCARE WEBSITES OneAshfield Ashfield Advisory Ashfield Engage Ashfield Health Sharp As of 2020, UDG Healthcare received an MSCI ESG Rating of AA. © 2021 UDG Healthcare. All rights reserved. Cookie policy Privacy policy Terms & conditions Anti Modern Slavery Policy Supplier Code of Conduct Sitemap MSCI ESG Disclaimer By Emperor By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Cookies Accept All Cookies